Enhancement of endothelial function inhibits left atrial thrombi development in an animal model of spontaneous left atrial thrombosis

Circulation Journal

Volumn 78, Issue 8, 2014, Pages 1980-1988

  Mawatari, Kazuaki ^a   Yoshioka, Emiko ^a   Toda, Satomi ^a   Yasui, Sonoko ^a   Furukawa, Hiroko ^a   Shimohata, Takaaki ^a   Ohnishi, Takamasa ^b   Morishima, Masaki ^c   Harada, Nagakatsu ^a   Takahashi, Akira ^a   Sakaue, Hiroshi ^a   Nakaya, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b HYOGO UNIVERSITY   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Endothelial dysfunction; Nitric oxide; Thrombosis; Vasodilation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS3 PROTEIN, RAT;

ANIMAL; DISEASE MODEL; ENDOTHELIUM; FEMALE; HEART ATRIUM; MALE; METABOLISM; PATHOLOGY; RAT; THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM; FEMALE; HEART ATRIA; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; THROMBOSIS;

EID: 84905043629     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1398     Document Type: Article

References (53)

1. Virchow R. Phlogose und thrombose im Gefäßsystem. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt: Staatsdruckerei, 1856.
2. Armstrong W, Golan DE, Tashjian AH, Armstrong E. Principles of pharmacology: The pathophysiologic basis of drug therapy. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008; 396.
3. Vinga C, de Rito V, Criconia GM, Russo A, Testa M, Fanell R, et al. Left atrial thrombus and spontaneous echo contrast in nonaniticoagulated mitral stenosis: A transesophageal echocardiographic study. Chest 1993; 103: 348-352.
4. Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force. Arch Neurol 1989; 46: 727-743.
5. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and thromboembolism in atrial fibrillation. Circ J 2012; 76: 2289-2304.
6. Ozer N, Tokgözoǧlu L, Ovünç K, Kabakçi G, Aksöyek S, Aytemir K, et al. Left atrial appendage function in patients with cardioembolic stroke in sinus rhythm and atrial fibrillation. J Am Soc Echocardiogr 2000; 13: 661-665.
7. Dubrava J, Garay R. The role of transesophageal echocardiography in detection of cardiogenic and aortic sources of embolism in stroke and transient ischaemic attacks. Vnitr Lek 2006; 52: 144-151.
8. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echo cardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969.
9. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21: 47-51.
10. Yamashita T, Sekiguchi A, Kato T, Tsuneda T, Iwasaki Y, Sagara K, et al. Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapid paced atria in rats. J Renin Angiotensin Aldosterone Syst 2007; 8: 127-132.
11. Joseph G, Walter J, David JW. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 2007; 51: 1790-1793.
12. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996; 32: 743-751.
14. Alonso D, Ranomski MW. Nitric oxide, platelet function, myocardial infarction and reperfusion therapies. Heart Fail Rev 2008; 8: 47-54.
15. Morishima-Yamato M, Hisaoka F, Shinomiya S, Harada N, Matoba H, Takahashi A, et al. Cloning and establishment of a line of rats for high levels of voluntary wheel running. Life Sci 2005; 77: 551-561.
16. Ohnishi T, Hisaoka F, Morishima M, Takahashi A, Harada N, Mawatari K, et al. Establishment of a model of Spontaneously-Running-Tokushima-Shikoku rats with left atrial thrombosis. J Toxicol Pathol 2014; 27: 51-56.
17. Hattori A, Mawatari K, Tsuzuki S, Yoshioka E, Toda S, Yoshida M, et al. Beta-adrenergic-AMPK pathway phosphorylates acetyl-CoA carboxylase in a high-epinephrine rat model, SPORTS. Obesity 2010; 18: 48-54.
18. 3- evaluation by an ion chromatography system. Biomed Chromatogr 1998; 12: 97-98.
19. 3- excretion in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure. Clin Sci (Lond) 1992; 82: 631-634.
20. Mawatari K, Kakui S, Harada N, Ohnishi T, Niwa Y, Okada K, et al. Endothelin-1(1-31) levels are increased in atherosclerotic lesions of the thoracic aorta of hypercholesterolemic hamsters. Atherosclerosis 2004; 175: 203-212.
21. Anderson JR. Disturbances of blood flow and body fluids. In: Anderson JR, editor. Muir's Textbook of Pathology, 11th edn. London, UK: Edward Arnold, 1980; 226-268.
22. Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008; 99: 995-1000.
23. Fukuchi M, Watanabe J, Kumagai K, Katori Y, Baba S, Fukuda K, et al. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 2001; 37: 1436-1442.
24. Sharmalar R, Chirkov YY. Platelet hyperaggregability: Impaired responsiveness to nitric oxide ("Platelet NO Resistance") as a therapeutic target. Cardiovasc Drugs Ther 2008; 22: 193-203.
25. Xiao XM, Li LP. L-Arginine treatment for asymmetric fetal growth restriction. Int J Gynaecol Obstet 2005; 88: 15-18.
26. Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke. Circulation 2002; 106: 2854-2858.
27. Yamashita T, Sekiguchi A, Iwasaki YK, Sagara K, Hatano S, Iinuma H, et al. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria. Circulation 2003; 108: 2450-2452.
28. Brass LF, Stalker TJ, Zhu L, Woulfe DS. Signal transduction during platelet plug formation. In: Michelson A, editor. Platelets, 2nd edn. San Diego: Academic Press, 2007; 319-346.
29. Chung I, Lip GY. Vichow's triad revisited: Blood constituents. Pathophysiol Haemost Thromb 2003; 33: 449-454.
30. Shirani J, Alaeddini J. Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolism and assessment by transesophageal echocardiography. Cardiovasc Pathol 2000; 9: 95-101.
31. Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice. Thromb Haemost 2008; 99: 264-270.
32. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: Possible involvement in intracardiac thrombogenesis. Thromb Res 2003; 111: 137-142.
33. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006; 27: 136-149.
34. Burstein SA. Cytokines, platelet production and hemostasis. Platelets 1997; 8: 93-104.
35. Amrani DL. Regulation of fibrinogen biosynthesis: Glucocorticoid and interleukin-6 control. Blood Coagul Fibrinolysis 1990; 1: 443-446.
36. Fluckiger JU, Goldberger JJ, Lee DC, Ng J, Lee R, Goyal A, et al. Left atrial flow velocity distribution and flow coherence using fourdimensional FLOW MRI: A pilot study investigating the impact of age and Pre-and Postintervention atrial fibrillation on atrial hemodynamics. J Magn Reson Imaging 2013; 38: 580-587.
37. Kronik G; the European Working Group on Echocardiography. The European Cooperative Study on the clinical significance of right heart thrombi: European Working Group on Echocardiography. Eur Heart J 1989; 10: 1046-1059.
38. Fukuchi M, Watanabe J, Kumagai K, Katori Y, Baba S, Fukuda K, et al. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 2001; 37: 1436-1442.
39. Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, et al. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: Results of the J-RHYTHM Registry. Circ J 2013; 77: 2264-2270.
40. Morishima M, Harada N, Hara S, Sano A, Seno H, Takahashi A, et al. Monoamine oxidase A activity and norepinephrine level in hippocampus determine hyperwheel running in SPORTS rats. Neuropsychopharmacology 2006; 31: 2627-2638.
41. Adrie C, Bloch KD, Moreno PR, Hurford WE, Guerrero JL, Holt R, et al. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation 1996; 94: 1919-1926.
42. Sun MW, Zhong MF, Gu J, Qian FL, Gu JZ, Chen H. Effect of different levels of exercise volume on endothelium-dependent vasodilation: Roles of nitric oxide synthase and heme oxygenase. Hypertension Res 2008; 31: 805-816.
43. Lowe GD. Virchow's triad revisited: Abnormal flow. Pathophysiol Haemost Thromb 2004; 33: 455-457.
44. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2008; 8: CD000990, doi:10.1002/14651858.CD000990.pub2.
45. Wang JS. Exercise prescription and thrombogenesis. J Biomed Sci 2006; 13: 753-761.
46. Davis MR, Ortegon DP, Kerby DJ, Ignarro LJ, Kashyap VS. Endothelial dysfunction after arterial thrombosis is ameliorated by L-arginine in combination with thrombolysis. J Vasc Interv Radiol 2003; 14: 233-239.
47. Lin PH, Johnson CK, Pullium JK, Bush RL, Conklin BS, Chen C, et al. L-arginine improves endothelial vasoreactivity and reduces thrombogenicity after thrombolysis in experimental deep venous thrombosis. J Vasc Surg 2003; 38: 1396-1403.
48. Takahashi N, Kume O, Wakisaka O, Fukunaga N, Teshima Y, Hara M, et al. Novel strategy to prevent atrial fibrosis and fibrillation. Circ J 2012; 76: 2318-2326.
49. Zhou X, Du JL, Yuan J, Chen YQ. Statin therapy is beneficial for the prevention of atrial fibrillation in patients with coronary artery disease: A meta-analysis. Eur J Pharmacol 2013; 707: 104-111.
50. Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: Updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2013; 2: e005033, doi:10.1161/JAHA.112.005033.
51. Shin SY, Na JO, Lim HE, Choi CU, Choi JI, Kin SH, et al. Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation. J Cardiovasc Electrophysiol 2011; 22: 376-382.
52. Costanzo S, di Niro V, Di Castelnuovo A, Gianfagna F, Donati MB, de Gaetano G, et al. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: An updated meta-analysis. J Thorac Cardiovasc Surg 2013; 146: 906-911.
53. Naji F, Sabovic M. The current role of statin therapy in the treatment of atrial fibrillation. Cardiovasc Hematol Agents Med Chem 2013; 11: 9-13.